首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function.
【24h】

The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function.

机译:CD244在慢性乙型肝炎感染中的免疫调节作用及其对病毒特异性CD8 + T细胞功能的抑制潜力。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Multiple inhibitory receptors may play a role in the weak or absent CD8+ T-cell response in chronic hepatitis B virus (HBV) infection. Yet few receptors have been characterized in detail and little is known about their complex regulation. In the present study, we investigated the role of the signaling lymphocyte activation molecule (SLAM)-related receptor CD244 and of programmed death 1 (PD-1) in HBV infection in 15 acutely and 66 chronically infected patients as well as 9 resolvers and 21 healthy controls. The expression of CD244, PD-1, and T-cell immunoglobulin domain and mucin domain 3 (TIM-3) was analyzed in virus-specific CD8+ T-cells derived from peripheral blood or liver using major histocompatibility complex class I pentamers targeting immunodominant epitopes of HBV, Epstein-Barr-virus (EBV), or influenza virus (Flu). In chronic HBV infection, virus-specific CD8+ T-cells expressed higher levels of CD244 both in the peripheral blood and liver in comparison to the acute phase of infection or following resolution. CD244 was expressed at similarly high levels in EBV infection, but was low on Flu-specific CD8+ T-cells. In chronic HBV infection, high-level CD244 expression coincided with an increased expression of PD-1. The inhibition of the CD244 signaling pathway by antibodies directed against either CD244 or its ligand CD48 resulted in an increased virus-specific proliferation and cytotoxicity as measured by the expression of CD107a, interferon-gamma, and tumor necrosis factor-alpha in CD8+ T-cells. Conclusion: CD244 and PD-1 are highly coexpressed on virus-specific CD8+ T-cells in chronic HBV infection and blocking CD244 or its ligand CD48 may restore T-cell function independent of the PD-1 pathway. CD244 may thus be another potential target for immunotherapy in chronic viral infections.
机译:在慢性乙型肝炎病毒(HBV)感染中,多种抑制性受体可能在CD8 + T细胞反应弱或缺乏中起作用。然而,很少有受体被详细表征,而对其复杂调控知之甚少。在本研究中,我们调查了15例急性和66例慢性感染患者以及9例解析者和21例HBV感染中与信号淋巴细胞活化分子(SLAM)相关的受体CD244和程序性死亡1(PD-1)的作用。健康对照。使用靶向免疫显性表位的主要组织相容性复合物I类五聚体,分析了外周血或肝中病毒特异性CD8 + T细胞中CD244,PD-1和T细胞免疫球蛋白域以及粘蛋白域3(TIM-3)的表达乙肝病毒,爱泼斯坦-巴尔病毒(EBV)或流感病毒(Flu)。在慢性HBV感染中,与感染的急性期或随后的消退相比,病毒特异性CD8 + T细胞在外周血和肝中均表达较高水平的CD244。 CD244在EBV感染中的表达水平相似,但在Flu特异性CD8 + T细胞中表达较低。在慢性HBV感染中,高水平的CD244表达与PD-1的表达增加相吻合。如通过CD8a + T细胞中CD107a,干扰素-γ和肿瘤坏死因子-α的表达所测量的,针对CD244或其配体CD48的抗体对CD244信号通路的抑制导致病毒特异性增殖和细胞毒性增加。 。结论:在慢性HBV感染中,CD244和PD-1在病毒特异性CD8 + T细胞上高度共表达,而阻断CD244或其配体CD48可恢复独立于PD-1途径的T细胞功能。因此,CD244可能是慢性病毒感染中免疫治疗的另一个潜在靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号